|
|
| |
Effective Treatment Options Available for Moderate to Severe Acne
Suffering from even a minor acne flair up can wreck your week, but suffering from continual moderate to serious acne can ruin your self esteem. There are options that can help you if you have moderate to severe acne. One of the most common...
Finding Acne Skin Care Products That Work For You
Each one of us is different, and nowhere is this more apparent than in the acne skin care products that work for each of us. Acne can be an upsetting condition, and finding a product that makes a real difference to the quality of our skin can be a...
Natural Herbal Skin Care
Natural herbal skin care has been the choice of beautiful women the world over for thousands of years. It has only been recently that cosmetic companies have formulated makeup and skin care products that contain chemicals and artificial additives...
Shoulder and Back Acne
If you suffer from shoulder and back acne, I have found a treatment that may help. Acuzine is a new non-prescription acne treatment. Acne is caused from imbalances and impurities within the body, and that's why we treat the problem an internal...
The natural remedy for acne
Acne can be one of the most distressing of afflictions, given that it tends to strike during the teens (although it can, of course, occur at any time of life too). As a highly visible problem, acne can cause acute embarrassment at the very time when...
|
|
| |
|
|
|
|
Acne: FDA Approved Aczone For Acne Treatment
The U.S. Food and Drug Administration
(FDA) approved to market Aczone
(dapsone) Gel, 5 per cent
for acne vulgaris topical
treatment. But patients who
have the enzyme deficiency,
G6PD (Glucose 6-phosphate
dehydrogenase), will need
to be monitored with regular
blood counts to detect if
they are predisposed to one
type of anemia (hemolytic
anemia).
Aczone, a trademark of QLT
USA Inc., is an aqueous topical
gel which contains 5 per cent
dapsone. According to scientific
research, combining dapsone
in a Solvent Microparticulate
(SMP) gel enables dapsone
to be applied topically and
safely. This product achieved
significant per cent reduction
in the number of acne lesions
and better success rate on
the Global Acne Assessment
Score in two randomized double-blind,
vehicle controlled clinical
studies in 3000 acne patients.
Oiliness/peeling, dryness,
and erythema were the most
common adverse events reported
from controlled clinical trials.
However, there were no significant
differences in the adverse
event rates between Aczone
Gel and vehicle control treated
patients.
1.4 per cent of about 3500
patients had the enzyme deficiency
-in the Aczone clinical trial
program- which is consistent
with the incidence in the
general North American population.
The company QLT will undertake
a post-approval Phase IV study
in 50 acne patients who have
G6PD deficiency and follow
them for 6 months, after which
QLT expects to submit an application
to the FDA to re-evaluate
the Aczone label.
The President and Chief Executive
Officer of QLT Inc., Paul
Hastings, stated that "Aczone
represents an important clinical
advance in dermatology, has
demonstrated safety and efficacy
in over 4,000 patients. We
are very pleased with the
FDA's decision and confident
in Aczone's potential as a
new class of treatment for
acne patients". Article written
by Hector Milla, editor of
http://www.acnetreatment stips.com
, a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com
, visit for reviews and acne solution products information
. Thanks for use this article
in your website or ezine keeping
a live link.
About the author:
Hector Milla, editor of many
websites in different topics:Moreover
he has a degree in business
administration. http://www.disorderskin.com
Resources - Link Exchange
|
|
|
|
|
|
